Citi analyst Joanne Wuensch raised the firm’s price target on Medtronic (MDT) to $99 from $98 and keeps a Buy rating on the shares. The firm adjusted targets in medical technology as part of a Q2 earnings preview.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MDT:
- Medtronic appoints Spooner as CFO of MiniMed
- KKR, Medtronic, Disney, Circle, Barrick: Trending by Analysts
- Medtronic’s Loop Recorder Study: A Potential Game-Changer in Cardiac Diagnostics
- Medtronic’s Care-HF Study: A Milestone in Cardiac Resynchronization Therapy
- Medtronic’s CORE Study Update: Evaluating the Conducted AF-Response Algorithm